BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3054754)

  • 1. [The role of ciprofloxacine metabolites in its biliary and urinary elimination in man].
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):719-23. PubMed ID: 3054754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ciprofloxacine: evaluation of its biliary elimination in man].
    Brogard JM; Jehl F; Arnaud JP; Lévy P; Peladan F; Blicklé JF; Monteil H
    Schweiz Med Wochenschr; 1985 Mar; 115(13):448-53. PubMed ID: 3158073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transfer of ciprofloxacin to bile and determination of biliary metabolites in humans.
    Tanimura H; Tominaga S; Rai F; Matsumoto H
    Arzneimittelforschung; 1986 Sep; 36(9):1417-20. PubMed ID: 3790196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary elimination of ticarcillin plus clavulanic acid (Claventin): experimental and clinical study.
    Brogard JM; Jehl F; Blickle JF; Adloff M; Dorner M; Montell H
    Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):135-44. PubMed ID: 2722309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High biliary elimination of ceftriaxone in man.
    Brogard JM; Blickle JF; Jehl F; Arnaud JP; Paris-Bockel D; Monteil H
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):167-72. PubMed ID: 3403093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary pharmacokinetic profile of piperacillin: experimental data and evaluation in man.
    Brogard JM; Jehl F; Blickle JF; Dorner M; Arnaud JP; Monteil H
    Int J Clin Pharmacol Ther Toxicol; 1990 Nov; 28(11):462-70. PubMed ID: 2272706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ceftriaxone, a cephalosporin with high hepatic elimination. Evaluation of its biliary clearance in man. Therapeutic value].
    Brogard JM; Jehl F; Paris-Bockel D; Sini F; Blickle JF; Adloff M; Monteil H
    Schweiz Med Wochenschr; 1987 Oct; 117(40):1549-59. PubMed ID: 3672089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An overview of the pharmacology of intravenously administered ciprofloxacin.
    Drusano GL
    Am J Med; 1987 Apr; 82(4A):339-45. PubMed ID: 3578325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids.
    Krol GJ; Beck GW; Benham T
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):181-90. PubMed ID: 8833981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel carbamate metabolites of mofegiline, a primary amine monoamine oxidase B inhibitor, in dogs and humans.
    Dow J; Piriou F; Wolf E; Dulery BD; Haegele KD
    Drug Metab Dispos; 1994; 22(5):738-49. PubMed ID: 7835226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cefixime biliary disposition in the isolated perfused rabbit liver model and in humans.
    Westphal JF; Brogard JM; Jehl F; Schloegel M; Blickle JF; Monteil H
    Drugs Exp Clin Res; 1992; 18(8):329-36. PubMed ID: 1292915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and structural elucidation of urinary metabolites of ciprofloxacin.
    Gau W; Kurz J; Petersen U; Ploschke HJ; Wuensche C
    Arzneimittelforschung; 1986 Oct; 36(10):1545-9. PubMed ID: 3814216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental and clinical evaluation of the biliary pharmacokinetic profile of cefpiramide, a new cephalosporin with high hepatic elimination.
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Drugs Exp Clin Res; 1988; 14(8):519-27. PubMed ID: 3248507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary elimination of apalcillin: an experimental and clinical study.
    Brogard JM; Arnaud JP; Blickle JF; Dorner M; Lautier F
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):180-7. PubMed ID: 3710630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the metabolites of roxithromycin in humans.
    Zhong D; Li X; Wang A; Xu Y; Wu S
    Drug Metab Dispos; 2000 May; 28(5):552-9. PubMed ID: 10772634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary elimination and hepatic disposition of a new fluoroquinolone, temafloxacin: experimental evaluation.
    Brogard JM; Koechlin C; Westphal JF; Blicklé JF; Dorner M; Jehl F
    Drugs Exp Clin Res; 1990; 16(8):407-16. PubMed ID: 2097145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biotransformation of tramadol in man and animal (author's transl)].
    Lintz W; Erlaçin S; Frankus E; Uragg H
    Arzneimittelforschung; 1981; 31(11):1932-43. PubMed ID: 7198474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans.
    Brogard JM; Jehl F; Monteil H; Adloff M; Blickle JF; Levy P
    Antimicrob Agents Chemother; 1985 Aug; 28(2):311-4. PubMed ID: 2939796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biliary excretion of benzbromarone and its hydroxilated main metabolites in humans.
    Walter-Sack I; de Vries JX; Ittensohn A; Raedsch R
    Eur J Med Res; 1998 Feb; 3(1-2):45-9. PubMed ID: 9512967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.